H. Kotzmann

1.1k total citations
26 papers, 816 citations indexed

About

H. Kotzmann is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Nephrology. According to data from OpenAlex, H. Kotzmann has authored 26 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Oncology and 4 papers in Nephrology. Recurrent topics in H. Kotzmann's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). H. Kotzmann is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). H. Kotzmann collaborates with scholars based in Austria, Germany and Czechia. H. Kotzmann's co-authors include Ursula Barnas, Heinz Gisslinger, E. Fritz, P Höcker, Heinz Ludwig, Michaela Riedl, Martin Clodi, Anton Luger, P. Bernecker and G Geyer and has published in prestigious journals such as New England Journal of Medicine, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

H. Kotzmann

26 papers receiving 775 citations

Peers

H. Kotzmann
Peter Carey United Kingdom
Peale Chuang United States
Özkan Sayan Türkiye
Lawrence R. Solomon United States
Oktay Bilgir Türkiye
J. H. Darley United Kingdom
H. Kotzmann
Citations per year, relative to H. Kotzmann H. Kotzmann (= 1×) peers Ichiro Koni

Countries citing papers authored by H. Kotzmann

Since Specialization
Citations

This map shows the geographic impact of H. Kotzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kotzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kotzmann more than expected).

Fields of papers citing papers by H. Kotzmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kotzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kotzmann. The network helps show where H. Kotzmann may publish in the future.

Co-authorship network of co-authors of H. Kotzmann

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kotzmann. A scholar is included among the top collaborators of H. Kotzmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kotzmann. H. Kotzmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotzmann, H., Michaela Riedl, Peter Pietschmann, et al.. (2004). Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis. Journal of Nephrology. 17(1). 87–94. 12 indexed citations
2.
Schmidt, Alice, Christina Maier, Michaela Riedl, et al.. (2004). Normal regulation of elevated plasma ghrelin concentrations in dialysis patients. Wiener klinische Wochenschrift. 116(7-8). 235–239. 6 indexed citations
3.
Kotzmann, H., Alice Schmidt, Ernst Schuster, et al.. (2003). One-Year Growth Hormone Therapy Improves Granulocyte Function without Major Effects on Nutritional and Anthropometric Parameters in Malnourished Hemodialysis Patients. Nephron Clinical Practice. 93(2). c75–c82. 5 indexed citations
4.
Kotzmann, H., Michaela Riedl, Alice Schmidt, et al.. (2001). Differential effects of growth hormone therapy in malnourished hemodialysis patients. Kidney International. 60(4). 1578–1585. 37 indexed citations
5.
Scheuba, Christian, Klaus Kaserer, H. Kotzmann, et al.. (2000). Prevalence of C-Cell Hyperplasia in Patients with Normal Basal and Pentagastrin-Stimulated Calcitonin. Thyroid. 10(5). 413–416. 27 indexed citations
6.
Riedl, Michaela, Martin Clodi, H. Kotzmann, et al.. (2000). Apoplexy of a pituitary macroadenoma with reversible third, fourth and sixth cranial nerve palsies following administration of hypothalamic releasing hormones: MR features. European Journal of Radiology. 36(1). 1–4. 19 indexed citations
7.
Kotzmann, H., Michaela Riedl, P. Bernecker, et al.. (1998). Effect of Long-Term Growth-Hormone Substitution Therapy on Bone Mineral Density and Parameters of Bone Metabolism in Adult Patients with Growth Hormone Deficiency. Calcified Tissue International. 62(1). 40–46. 42 indexed citations
8.
Clodi, Martin, Michaela Riedl, Sabine Schmaldienst, et al.. (1998). Adrenal function in patients with chronic renal failure. American Journal of Kidney Diseases. 32(1). 52–55. 35 indexed citations
9.
Kotzmann, H., Claudette Abela, Martin Clodi, et al.. (1997). Effect of Successful Parathyroidectomy on Hematopoietic Progenitor Cells and Parameters of Red Blood Cells in Patients with Primary Hyperparathyroidism. Hormone and Metabolic Research. 29(8). 387–392. 11 indexed citations
10.
Clodi, Martin, H. Kotzmann, Michaela Riedl, et al.. (1997). The long-acting dopamine agonist bromocriptine mesylate as additive immunosuppressive drug after kidney transplantation. Nephrology Dialysis Transplantation. 12(4). 748–752. 2 indexed citations
11.
Köller, Marcus, H. Kotzmann, Martin Clodi, Michaela Riedl, & A Luger. (1997). Effect of elevated serum prolactin concentrations on the immunophenotype of human lymphocytes, mitogen‐induced proliferation and phagocytic activity of polymorphonuclear cells. European Journal of Clinical Investigation. 27(8). 662–666. 9 indexed citations
12.
Kotzmann, H., Michaela Riedl, Martin Clodi, et al.. (1996). The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency. European Journal of Clinical Investigation. 26(12). 1175–1181. 28 indexed citations
13.
Kotzmann, H., Bernhard Ludvik, Martin Clodi, et al.. (1995). Effect of danazol‐induced chronic hyperglucagonaemia on glucose tolerance and turnover. European Journal of Clinical Investigation. 25(12). 942–947. 2 indexed citations
14.
Locker, Gottfried J., H. Kotzmann, Bernhard Frey, et al.. (1995). Factitious Hyperthyroidism Causing Acute Myocardial Infarction. Thyroid. 5(6). 465–467. 23 indexed citations
15.
Svoboda, Thomas, H. Kotzmann, Martin Clodi, et al.. (1994). The Non Ergot D2-Dopamine Agonist CV 205–502 Decreases Growth Hormone Concentrations in Acromegalic Patients. Endocrine Research. 20(1). 59–63. 3 indexed citations
16.
Kotzmann, H., Martin Clodi, Thomas Svoboda, et al.. (1994). Effect of Elevated Growth Hormone Concentrations on the Phenotype and Functions of Human Lymphocytes and Natural Killer Cells. Neuroendocrinology. 60(6). 618–625. 16 indexed citations
17.
Kotzmann, H., P. Bernecker, P. Hübsch, et al.. (1993). Bone mineral density and parameters of bone metabolism in patients with acromegaly. Journal of Bone and Mineral Research. 8(4). 459–465. 80 indexed citations
18.
Kotzmann, H. & Heinz Gisslinger. (1992). Treatment and Prophylaxis of Chemotherapy-Induced Gastrointestinal Complaints. Scandinavian Journal of Gastroenterology. 27(sup191). 12–15. 1 indexed citations
19.
Ludwig, H., E. Fritz, H. Kotzmann, & Heinz Gisslinger. (1990). Erythropoietin-Behandlung der tumorassoziierten Anämie bei Patienten mit multiplem Myelom. Oncology Research and Treatment. 13(1). 46–49. 2 indexed citations
20.
Ludwig, Heinz, E. Fritz, H. Kotzmann, et al.. (1990). Erythropoietin Treatment of Anemia Associated with Multiple Myeloma. New England Journal of Medicine. 322(24). 1693–1699. 340 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026